IL207367A0 - Certain chemical entities, compositions, and methods - Google Patents

Certain chemical entities, compositions, and methods

Info

Publication number
IL207367A0
IL207367A0 IL207367A IL20736710A IL207367A0 IL 207367 A0 IL207367 A0 IL 207367A0 IL 207367 A IL207367 A IL 207367A IL 20736710 A IL20736710 A IL 20736710A IL 207367 A0 IL207367 A0 IL 207367A0
Authority
IL
Israel
Prior art keywords
compositions
methods
chemical entities
certain chemical
certain
Prior art date
Application number
IL207367A
Other languages
English (en)
Original Assignee
Cytokinetics Inc
Luke W Ashcraft
Bradley p morgan
Alex Muci
Zhe Yang
Scott Collibee
Wang Jianchao
Jeff Gardina
Brian Stoltz
Bergnes Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics Inc, Luke W Ashcraft, Bradley p morgan, Alex Muci, Zhe Yang, Scott Collibee, Wang Jianchao, Jeff Gardina, Brian Stoltz, Bergnes Gustave filed Critical Cytokinetics Inc
Publication of IL207367A0 publication Critical patent/IL207367A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
IL207367A 2008-02-04 2010-08-02 Certain chemical entities, compositions, and methods IL207367A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2606708P 2008-02-04 2008-02-04
PCT/US2009/000686 WO2009099594A1 (en) 2008-02-04 2009-02-02 Certain chemical entities, compositions and methods

Publications (1)

Publication Number Publication Date
IL207367A0 true IL207367A0 (en) 2010-12-30

Family

ID=40952391

Family Applications (1)

Application Number Title Priority Date Filing Date
IL207367A IL207367A0 (en) 2008-02-04 2010-08-02 Certain chemical entities, compositions, and methods

Country Status (18)

Country Link
US (2) US7989469B2 (enExample)
EP (1) EP2244711A4 (enExample)
JP (1) JP2011510985A (enExample)
KR (1) KR20100119773A (enExample)
CN (1) CN101983061A (enExample)
AR (1) AR072242A1 (enExample)
AU (1) AU2009210787A1 (enExample)
BR (1) BRPI0907502A2 (enExample)
CA (1) CA2713864A1 (enExample)
CL (1) CL2009000246A1 (enExample)
CO (1) CO6290673A2 (enExample)
EA (1) EA201001224A1 (enExample)
EC (2) ECSP10010430A (enExample)
IL (1) IL207367A0 (enExample)
MX (1) MX2010008518A (enExample)
TW (1) TW200946524A (enExample)
WO (1) WO2009099594A1 (enExample)
ZA (1) ZA201005780B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
CN101983061A (zh) * 2008-02-04 2011-03-02 赛特凯恩蒂克公司 某种化学物质、组合物和方法
CN102127070A (zh) * 2010-01-15 2011-07-20 山东轩竹医药科技有限公司 吡啶并环衍生物
EP2730575B1 (en) * 2011-07-09 2015-09-16 Xuanzhu Pharma Co., Ltd. Crystal form i of salt of dipeptidyl peptidase-iv inhibitor and preparation method and use thereof
US10272082B2 (en) 2011-07-13 2019-04-30 Cytokinetics, Inc. Combination ALS therapy
EA032480B1 (ru) * 2012-04-11 2019-06-28 Сайтокинетикс, Инк. Способы повышения устойчивости скелетных мышц к утомлению
PL3137622T3 (pl) 2014-04-29 2022-05-09 Cytokinetics, Inc. Sposoby redukowania spadku pojemności życiowej
TW201927738A (zh) * 2017-12-14 2019-07-16 丹麥商Ｎｍｄ藥品公司 用於治療神經肌肉病症的化合物
TWI794369B (zh) * 2017-12-14 2023-03-01 丹麥商Ｎｍｄ藥品公司 用於治療神經肌肉病症的化合物
WO2020240586A1 (en) * 2019-05-28 2020-12-03 Mankind Pharma Ltd. Novel compounds for inhibition of janus kinase 1
EP4333982A1 (en) * 2021-05-06 2024-03-13 Exscientia Al Limited Pkc-theta modulators
CN118702622A (zh) * 2024-08-30 2024-09-27 阜新达得利化工股份有限公司 一种3-溴-2-氰基吡啶的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0206860D0 (en) * 2002-03-22 2002-05-01 Glaxo Group Ltd Compounds
GB0212048D0 (en) * 2002-05-24 2002-07-03 Merck Sharp & Dohme Therapeutic agents
WO2004043913A2 (en) 2002-11-08 2004-05-27 Trimeris, Inc. Hetero-substituted benzimidazole compounds and antiviral uses thereof
CN1816530A (zh) 2003-07-01 2006-08-09 麦克公司 用于治疗高眼压症的眼用组合物
US20050250794A1 (en) 2003-12-19 2005-11-10 Andrew Napper Methods of treating a disorder
AU2005208938A1 (en) 2004-01-29 2005-08-11 Elixir Pharmaceuticals, Inc Anti-viral therapeutics
WO2005108374A1 (en) 2004-04-29 2005-11-17 Fmc Corporation Insecticidal diazole and triazole derivatives
GB0420719D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
US7718657B2 (en) 2005-12-16 2010-05-18 Cytokinetics, Inc. Certain indanyl urea modulators of the cardiac sarcomere
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
DK2069352T5 (en) 2006-08-02 2017-04-03 Cytokinetics Inc SPECIFIC CHEMICAL UNITS, COMPOSITIONS AND PROCEDURES
CL2007002994A1 (es) 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
US7981893B2 (en) 2006-10-19 2011-07-19 Signal Pharmaceuticals, Llc Heteroaryl compounds, compositions thereof, and methods of treatment therewith
WO2008075007A1 (en) * 2006-12-21 2008-06-26 Cancer Research Technology Limited Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents
EP2139478A4 (en) 2007-03-30 2010-05-05 Cytokinetics Inc CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
US7998976B2 (en) 2008-02-04 2011-08-16 Cytokinetics, Inc. Certain chemical entities, compositions and methods
CN101983061A (zh) * 2008-02-04 2011-03-02 赛特凯恩蒂克公司 某种化学物质、组合物和方法
AU2009324894B2 (en) 2008-11-25 2015-04-09 University Of Rochester MLK inhibitors and methods of use

Also Published As

Publication number Publication date
BRPI0907502A2 (pt) 2019-01-15
AR072242A1 (es) 2010-08-18
EP2244711A1 (en) 2010-11-03
AU2009210787A1 (en) 2009-08-13
MX2010008518A (es) 2010-11-10
JP2011510985A (ja) 2011-04-07
US20090253737A1 (en) 2009-10-08
KR20100119773A (ko) 2010-11-10
CA2713864A1 (en) 2009-08-13
CL2009000246A1 (es) 2009-06-26
CO6290673A2 (es) 2011-06-20
US20110312975A1 (en) 2011-12-22
TW200946524A (en) 2009-11-16
ECSP10010432A (es) 2011-01-31
EP2244711A4 (en) 2011-08-24
WO2009099594A1 (en) 2009-08-13
EA201001224A1 (ru) 2011-08-30
ECSP10010430A (es) 2011-02-28
ZA201005780B (en) 2011-04-28
US7989469B2 (en) 2011-08-02
CN101983061A (zh) 2011-03-02

Similar Documents

Publication Publication Date Title
IL242192A (en) Certain chemicals, preparations and methods
ZA201200254B (en) Certain chemical entities,compositions and methods
EP2195328A4 (en) PARTICULAR CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
ZA200900976B (en) Certain chemical entities,compositions and methods
EP2139478A4 (en) CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
ZA201005780B (en) Certain chemical entities,compositions and methods
PL2271725T3 (pl) Kompozycje zawierające 2,3,3,3-tetrafluoropropen i 1,1,1-trifluoropropen
GB0819530D0 (en) Methods and compositions
GB0706077D0 (en) Methods, Compositions and uses thereof
EP2320910A4 (en) CHEMICAL COMPOUNDS AND ITS USE
GB0601143D0 (en) Uses, methods and compositions
EP2609108A4 (en) Specific chemical substances, compositions and methods
PL2262828T3 (pl) Kompozycje, sposoby i zestawy
SI2069352T1 (sl) Določene kemijske entitete, sestavki in postopki
ZA201101520B (en) Phenanthrenone compounds,compositions and methods
PL2376479T3 (pl) Podstawione furanokarboksyamidy i ich zastosowanie
GB0811250D0 (en) Methods and compositions
EP2114156A4 (en) Chemical compounds, pharmaceutical compositions and corresponding methods
HK1149204A (en) Certain chemical entities, compositions and methods
GB0803464D0 (en) Methods and compositions
GB0818399D0 (en) Methods and compositions
GB0811152D0 (en) Methods and compositions
GB0816534D0 (en) Compositions and methods
GB0821348D0 (en) Compounds and preparation methods